Upload lyliem
View 213
Download 0
Embed Size (px) 344 x 292 429 x 357 514 x 422 599 x 487
Citation preview
Supplementary guidelines on good manufacturing …apps.who.int/medicinedocs/documents/s20109en/s20109en.pdfSupplementary guidelines on good manufacturing practices for the manufacture
POLITICA NACIONAL DE MEDICAMENTOS - …apps.who.int/medicinedocs/documents/s22366es/s22366es.pdf · Especialidad farmacéutica: todo medicamento, designado por un nombre convencional,
Measuring medicine prices, availability, affordability and ...apps.who.int/medicinedocs/documents/s14868e/s14868e.pdf · MEASURING MEDICINE PRICES, AVAILABILITY, AFFORDABILITY AND
BIOMATERIAL & BIOCOMPATIBILITY TEsTIng …apps.who.int/medicinedocs/documents/s22132en/s22132en.pdf · requirements (for example, a “smart bomb” drug delivery system that targets
LOGISTICS MANAGEMENT INFORMATION SYSTEM …apps.who.int/medicinedocs/documents/s21037en/s21037en.pdf · Karnataka State, India: ... 7 Findings and Recommendations .....9 Logistics
Clinical evidence for medical devices: regulatory ...apps.who.int/medicinedocs/documents/s17698en/s17698en.pdfregulatory processes focussing on Europe ... of medical device users,
Pharmaceutical System Strengthening Interventions to ...apps.who.int/medicinedocs/documents/s21842en/s21842en.pdf · Pharmaceutical System Strengthening Interventions to Improve Access
International price comparison of pharmaceuticals …apps.who.int/medicinedocs/documents/s23166en/s23166en.pdfInternational price comparison of pharmaceuticals 2016 ... Ceiling prices
PHARMACEUTICALS: RESTRICTIONS IN USE AND AVAILABILITY …apps.who.int/medicinedocs/documents/s17126e/s17126e.pdf · PHARMACEUTICALS: RESTRICTIONS IN USE AND AVAILABILITY Prepared
Systems Requirements for Computerized Medicine ...apps.who.int/medicinedocs/documents/s21705en/s21705en.pdf · Systems Requirements for Computerized Medicine Registration, Mozambique
International Nonproprietary Names (INN) for ...apps.who.int/medicinedocs/pdf/s4894e/s4894e.pdf · International Nonproprietary Names (INN) for pharmaceutical substances Names for
International Policy Overview: Antibiotic Resistance - …apps.who.int/medicinedocs/documents/s19478en/s19478en.pdf · International Policy Overview: ... This policy overview is linked
Medicine prices, availability, affordability and price …apps.who.int/medicinedocs/documents/s16180e/s16180e.pdfMedicine prices, availability, affordability and price components:
Rapid Pharmaceutical Management Assessment: …apps.who.int/medicinedocs/documents/s18650en/s18650en.pdfRAPID PHARMACEUTICAL MANAGEMENT ASSESSMENT: AN INDICATOR-BASED APPROACH July
ANTIBIOTIC RESISTANCE: MULTI-COUNTRY …apps.who.int/medicinedocs/documents/s22245en/s22245en.pdfAntibiotic Resistance: Multi-country public awareness survey 3 which conditions can
Awareness Workshop on Bangladesh Common Technical …apps.who.int/medicinedocs/documents/s23064en/s23064en.pdf · improving governance, building capacity for pharmaceutical management
Australian Guideline for Pharmacovigilance ...apps.who.int/medicinedocs/documents/s17999en/s17999en.pdf · Australian Guideline for Pharmacovigilance Responsibilities of Sponsors
Active Pharmacovigilance Surveillance: Drug Safety ...apps.who.int/medicinedocs/documents/s22109en/s22109en.pdf · Standard Operating Procedures Active Pharmacovigilance Surveillance:
Pharmaceutical regulation in 15 European countries - …apps.who.int/medicinedocs/documents/s23163en/s23163en.pdf · Pharmaceutical regulation in 15 European countries Review Vol
Alternative Public Health Supply Chains: Reconsidering …apps.who.int/medicinedocs/documents/s20238en/s20238en.pdf · Alternative Public Health Supply Chains: ... Alternative Public
Practical Guidelines on Pharmaceutical Procurement …apps.who.int/medicinedocs/pdf/h2999e/h2999e.pdf · Practical Guidelines on Pharmaceutical Procurement for ... Practical Guidelines
Health Technologies and Pharmaceuticals (HTP) programme …apps.who.int/medicinedocs/documents/s21367en/s21367en.pdf · Health Technologies and Pharmaceuticals WHO Xxxxxxxxxxxxxx
Initiation and Implementation of a Pharmacovigilance ...apps.who.int/medicinedocs/documents/s21024en/s21024en.pdf · Initiation and Implementation of a Pharmacovigilance System in
Afghanistan Medicines Sampling and Testing – A ...apps.who.int/medicinedocs/documents/s20276en/s20276en.pdf · Afghanistan Medicines Sampling and Testing – A Quantitative
N E STRATEGIC PLAN FOR P HUMAN RESOURCES FOR HEALTH …apps.who.int/medicinedocs/documents/s18827en/s18827en.pdf · A Complementary Report to the Strategic plan for Human Resources
GOOD MANUFACTURING PRACTICE GUIDELINE FOR PHARMACEUTICAL ...apps.who.int/medicinedocs/documents/s22357en/s22357en.pdf · Ethiopian Food, Medicine & Healthcare Administration & Control
THE MECTIZAN' (IVERMECTIN) DONATION PROGRAM …apps.who.int/medicinedocs/documents/s17517en/s17517en.pdf · Polio oral polio vaccine Aventis Pasteur ... emergency' in nature,
NAFDAC GOOD PHARMACOVIGILANCE PRACTICE GUIDELINES 2016 …apps.who.int/medicinedocs/documents/s23028en/s23028en.pdf · nafdac good pharmacovigilance practice guidelines 2016 ... periodic
NATIONAL MALARIA POLICY - WHO | World Health ...apps.who.int/medicinedocs/documents/s19266en/s19266en.pdfNATIONAL MALARIA POLICY Directorate: Special Programmes Division: Health sector
Recommendations for Advancing Pharmacy Education …apps.who.int/medicinedocs/documents/s21918en/s21918en.pdf · Education in the Democratic Republic of the Congo. ... Introduction
